References
- Ng YS, Stein J, Ning M, Black-Schaffer RM. Comparison of clinical characteristics and functional outcomes of ischemic stroke in different vascular territories. Stroke. 2007 ; 38(8) : 2309-14. https://doi.org/10.1161/STROKEAHA.106.475483
- Alberts MJ, Ovbiagele B. Current strategies for ischemic stroke prevention: role of multimodal combination therapies. J Neurol. 2007 ; 254(10) : 1414-26. https://doi.org/10.1007/s00415-007-0569-9
- Eom YH. Eomssijesaeng-bang. Beijing : Renminweisheng-chubanshe. 1980 : 79.
- Yun GY. Dongui-imsangbangjehak. Seoul : Myeongbo-chulpansa. 1985 : 99.
- Wang A. Uibangjipae. Seoul : Seongbo-sa. 1983 : 314-6.
- Sin WT, Heo JE, Kim TH, Hong SH, Kwon OS, Kim KT, Hong SH. Clinical effect of Dodam-tang on hyperlipidemia. J Kor Orien Intern Med. 2007 ; 10(1) : 113-8.
- Kim YD, Mun BS, Park YS, Kim SG. Effects of Dodamtang on the Hyperlipidemia and Intravascular Coagulation Induced Rabbits. J Trad Kor Med. 1994 ; 4(1) : 85-128.
- Kim TS, An GS. Effect of Dangkwisoosan and Dodamtang on the Intravascular Coagulation Induced by Endotoxin in Rats. Kor J Orien Pathol. 1988 ; 3(1) : 91-8.
- Cho HK, Im SM, An JJ, Choe Y, Kim YJ, Yu HR, Park YC, Seol IC, Hwang CW. Effect of Dodamtang (DDT) on Brain damage and Hypertension. J Kor Orien Internal Med. 2001 ; 22(4) : 503-12.
- Pinto A, Tuttolomondo A, Di Raimondo D, Fernandez P, Licata G. Cerebrovascular risk factors and clinical classification of strokes. Semin Vasc Med. 2004 ; 4(3) : 287-303. https://doi.org/10.1055/s-2004-861497
- Futterman LG, Lemberg L. Stroke risk, cholesterol and statins. Am J Crit Care. 1999 ; 8(6) : 416-9.
- Sin GJ, Park SS. A Study on the level of Serum Lipids in Stroke. J Korean Inst Orient Med Inform. 1995 ; 1(1) : 37-55.
- Kim YS. Integrated clinical approach to stroke. Seoul : Seowon-dang. 1997 : 335-48.
- Chae IS. Hanbang-imsanghak. Seoul : Daeseongmunhwasa. 1987 : 145-50.
- Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. stroke. 1989 ; 20(1) : 84-91. https://doi.org/10.1161/01.STR.20.1.84
- Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. A semiautomated method for measuring brain infarct volume. J Cereb Blod Flow Metab. 1990 ; 10(2) : 290-3. https://doi.org/10.1038/jcbfm.1990.47
- Simons LA, McCallum J, Friedlander Y, Simons J. Risk factors for ischemic stroke: Dubbo Study of the elderly. Stroke. 1998 ; 29(7) : 1341-6. https://doi.org/10.1161/01.STR.29.7.1341
- Lee DS, Sin GJ, Cho GH, Kim YS, Bae HS, Lee KS. Experimental study on the effects of Chungyeuldodamtang upon hypertension and hyperlipidemia. J Kor Orien Intern Med. 1992 ; 12(2) : 16-25.
- Park WH. A Study on The Effects of The Pungwidodamtang on High Lipid Diethyperlipidemia Rats. Kor J Orien Pathol. 1996 ; 10(2) : 103-11.
- Park WH, Choe DY, Mun JJ. A Study of the influence of both of Shunqidaotantang and Huayutnag on thrombosis, contysion-hyperemia, and hyperlipidemia. J Dongguk Resear Instit Orien Med. 1993 ; 2(1) : 19-54.
- Hawkins BT, Davis TP. The Blood-Brain Barrier/Neurovascular Unit in Health and Disease. Pharmacol Rev. 2005 ; 57(2) : 173-85. https://doi.org/10.1124/pr.57.2.4
- Abbott NJ, Ronnback L, Hansson E. Astrocyteendothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2006 ; 7(1) : 41-53. https://doi.org/10.1038/nrn1824
- Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol. 2006 ; 1(3) : 223-36. https://doi.org/10.1007/s11481-006-9025-3
- Thiel VE, Audus KL. Nitric oxide and blood-brain barrier integrity. Antioxid Redox Signal. 2001 ; 3 : 273-8. https://doi.org/10.1089/152308601300185223
- Yong VW, Kerkoski CA, Forsyth PA, Bell R, Edwards DR. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 1998 ; 21(2): 75-80. https://doi.org/10.1016/S0166-2236(97)01169-7
-
Luo CX, Zhu XJ, Zhang AX, Wang W, Yang XM, Liu SH, Han X, Sun J, Zhang SG, Lu Y, Zhu DY. Blockade of L-type voltagegated
$Ca^{2+}$ channel inhibits ischemia-induced neurogenesis by downregulating iNOS expression in adult mouse. J Neurochem. 2005 ; 94(4) : 1077-86. https://doi.org/10.1111/j.1471-4159.2005.03262.x - Zhu DY, Deng Q, Yao HH, Wang DC, Deng Y, Liu GQ. Inducible nitric oxide synthase expression in the ischemic core andpenumbra after transient focal cerebral ischemia in mice. Life Sci. 2002 ; 71(17) : 1985-96. https://doi.org/10.1016/S0024-3205(02)01970-7
- Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994 ; 94(6) : 2493-503. https://doi.org/10.1172/JCI117619
- Winkler F, Koedel U, Kastenbauer S, Pfister HW. Differential expression of nitric oxide synthases in bacterial meningitis: role of the inducible isoform for blood-ibrain barrier breakdown. J Infect Dis. 2001 ; 183(12) : 1749-59. https://doi.org/10.1086/320730
- Tan KH, Harrington S, Purcell WM, Hurst RD. Peroxynitrite mediates nitric oxide-induced blood- kbrain barrier damage. Neurochem Res. 2004 ; 29(3) : 579-87. https://doi.org/10.1023/B:NERE.0000014828.32200.bd
- Khan M, Sekhon B, Giri S, Jatana M, Gilg AG, Ayasolla K, Elango C, Singh I. S-Nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke. J Cereb Blood Flow Metab. 2005 ; 25(2) : 177-92. https://doi.org/10.1038/sj.jcbfm.9600012
- Yurchenco PD, Schittny JC. Molecular architecture of basement membranes. FASEB J. 1990 ; 4(6) : 1577-90. https://doi.org/10.1096/fasebj.4.6.2180767
- Fukuda S, Fini CA, Mabuchi T, Koziol JA, Eggleston LLJ, del Zoppo GJ. Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke. 2004 ; 35(4) : 998-1004. https://doi.org/10.1161/01.STR.0000119383.76447.05
- Rosenberg GA, Navratil M, Barone F, Feuerstein G. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab. 1996 ; 16(3) : 360-6. https://doi.org/10.1097/00004647-199605000-00002
- Liu KJ, Rosenberg GA. Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radic Biol Med. 2005 ; 39(1) : 71-80. https://doi.org/10.1016/j.freeradbiomed.2005.03.033
- Gasche Y, Copin J-C, Sugawara T, Fujimura M, Chan PH. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab. 2001 ; 21(12) : 1393-400. https://doi.org/10.1097/00004647-200112000-00003
- Huber JD, Egleton RD, Davis TP. Molecular physiology and pathophysiology of tight junctions in the blood-rain barrier. Trends Neurosci. 2001 ; 24(12) : 719-25. https://doi.org/10.1016/S0166-2236(00)02004-X
- Pekny M, Pekna M. Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol. 2004 ; 204(4) : 428-37. https://doi.org/10.1002/path.1645